Home » Topics » BioWorld Science

BioWorld Science
RSS

New DDR1 and/or DDR2 inhibitors identified at Galapagos

Feb. 2, 2022

Science & Technology Development Fund Authority presents new antiviral nucleosides

Feb. 2, 2022

New murine model of AIH developed using a human liver protein

Feb. 2, 2022

Drug cocktail is step up for leg regeneration

Feb. 1, 2022

Celsion's DNA-based approach for SARS-CoV-2 vaccine to be studied in NHP challenge study

Feb. 1, 2022

Almirall signs agreements with Ablexis and AliviaMab to support work in dermatology

Feb. 1, 2022

Ethris to advance mRNA-based therapeutics for respiratory diseases

Feb. 1, 2022

Loss of miR-15a/miR-16-1 contributes to CLL development

Feb. 1, 2022

Novel CDK9 inhibitor inhibits osteosarcoma in patient-derived orthotopic xenografts

Feb. 1, 2022

DDO-02005, a novel potent Kv1.5 potassium channel inhibitor with antiarrhythmic activity

Feb. 1, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...